Prager J, Baumert A, Hermann J, Fuchs D, Zintl F
Universitäts-Kinderklinik, Jussuf Ibrahim, Jena.
Kinderarztl Prax. 1992 Jun;60(4-5):124-30.
Today BMT belongs to the established methods of treatment in haematology and oncology. Because of the constant increase of healthy long-term survivors after BMT the problem of immunological reconstitution and eventual possible late effects gets more and more importance. One problem, which til now has been few attention paid to, is that of the protection by vaccination after BMT. We report on the kinetics of the tetanus-antitoxin in 20 patients after allogeneic or autologous BMT and demonstrate the influence of a graft-versus-host disease and its therapy on the antibody kinetics. In the group of allogeneic transplanted children without a GvHD the tetanus-antitoxin titers felt below their detection range after a time of about 8 months whereas in the group with GvHD this effect already occurred after nearly 4 months. The autologous transplanted patients have a positive antibody level til the time of 20 months after BMT. As a consequence of the lost protection by vaccination after BMT follows the necessity of revaccinations respectively of boostering after immunological reconstitution.
如今,骨髓移植(BMT)属于血液学和肿瘤学中既定的治疗方法。由于骨髓移植后长期健康存活者不断增加,免疫重建问题以及最终可能出现的晚期效应变得越来越重要。到目前为止,一个很少受到关注的问题是骨髓移植后疫苗接种的保护作用。我们报告了20例异基因或自体骨髓移植患者破伤风抗毒素的动力学情况,并证明了移植物抗宿主病(GvHD)及其治疗对抗体动力学的影响。在没有发生移植物抗宿主病的异基因移植儿童组中,破伤风抗毒素滴度在大约8个月后降至检测范围以下,而在发生移植物抗宿主病的组中,这种效应在近4个月后就已出现。自体移植患者在骨髓移植后20个月时抗体水平仍为阳性。由于骨髓移植后疫苗接种保护作用的丧失,因此有必要在免疫重建后重新接种疫苗或加强免疫。